Frank Perabo - Concepedia

Author

Frank Perabo

Also Known As

F G E Perabo, F PERABO, F Perabo, F. G. E. Perabo, F. G.E. Perabo, F. Perabo, F.G. Perabo, F.G.E Perabo, F.G.E. Perabo, FRANK G.E. PERABO

101

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

University of Bonn University Hospital Bonn Klinik und Poliklinik für Urologie Astellas Pharma (United States)University of Copenhagen

About

Frank Perabo is an author at University of Bonn specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	20	896
2	Health Sciences	3	3	228
3	Cell Biology	3	3	82
4	Natural Sciences	1	1	26
5	Public Health	1	1	17

Frank Perabo

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, New England Journal of Medicine	2014	3K
Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial Yohann Loriot, Kurt Miller, Cora N. Sternberg, The Lancet Oncology UrologyHealth-related QualityPain MedicineMedicineSkeletal-related Events	2015	191
Treatment of penile strangulation caused by constricting devices Frank Perabo, Gabriel Steiner, Peter Albers, Urology Penile StrangulationErectile DysfunctionImplantable Device	2002	103
Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer Jörg Ellinger, Volker Wittkamp, Peter Albers, The Journal of Urology	2008	102
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study Bertrand Tombal, Michael Borre, Per Rathenborg, The Lancet Oncology UrologyOncologyMedicinePrimary AnalysisPharmacotherapy	2014	95
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer Christopher P. Evans, Celestia S. Higano, Thomas E. Keane, European Urology Baseline DiseaseUrologyGenitourinary CancerMedicineCancer Management	2016	90
CpG Island Hypermethylation of Cell-Free Circulating Serum DNA in Patients With Testicular Cancer Jörg Ellinger, Peter Albers, Frank Perabo, The Journal of Urology	2009	87
Gemcitabine Monotherapy as Second-Line Treatment in Cisplatin-Refractory Transitional Cell Carcinoma – Prognostic Factors for Response and Improvement of Quality of Life Peter Albers, Roswitha Siener, Michael Haertlein, Oncology Research and Treatment	2002	87
Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer Jörg Ellinger, Nadja El Kassem, Lukas C. Heukamp, The Journal of Urology	2007	79
Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer Emmanuel S. Antonarakis, Chandtip Chandhasin, Erica Osbourne, The Oncologist	2016	74

Page 1